Sosei Heptares and Neurocrine hope to be able to achieve the benefits of muscarinic agonists without the toxicity, in a single molecule. "Our selective muscarinic agonist approach is supported by ...

The start of mid-stage testing of PF-07081532 triggers a $10 million milestone payment to Sosei Heptares, which has been working with Pfizer on small-molecule drugs directed at G protein-coupled ...

Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...

Small molecules are low molecular weight molecules that include lipids, monosaccharides, second messengers, other natural products and metabolites, as well as drugs and other xenobiotics.

Tumbling to a price of $128.32 during today's morning trading session, shares of Neurocrine Biosciences are now -24.61% below their average target price of $170.22. Does this mean the stock will ...

Scotiabank lowered the firm’s price target on Agios Pharmaceuticals (AGIO) to $74 from $75 and keeps an Outperform rating on the shares. The firm is impressed by the company’s regulatory and ...

SAN DIEGO—Kevin Charles Gorman, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), sold a total of 5,844 shares of the company's common stock on February 13, 2025, according to a recent SEC ...

After hours: February 19 at 5:09:04 PM EST Loading Chart for UTHR ...